Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.

    Microvascular Decompression Could Offer Trigeminal Neuralgia Relief
    Source: Pixabay.com

    Microvascular Decompression Could Offer Trigeminal Neuralgia Relief

    Trigeminal neuralgia is characterized by intense and debilitating chronic pain affecting one side of the face. Currently, there are a number of treatment options to reduce pain: tricyclic antidepressants, anticonvulsants,…

    Continue Reading Microvascular Decompression Could Offer Trigeminal Neuralgia Relief
    Informing Treatment Decisions for Psoriatic Arthritis: A Discussion with Dr. Soumya Chakravarty
    source: pixabay.com

    Informing Treatment Decisions for Psoriatic Arthritis: A Discussion with Dr. Soumya Chakravarty

    From November 10-14, 2022, various stakeholders within the rheumatology sphere connected at the American College of Rheumatology’s (ACR) Convergence 2022. During ACR Convergence, described as the world’s premier rheumatology experience,…

    Continue Reading Informing Treatment Decisions for Psoriatic Arthritis: A Discussion with Dr. Soumya Chakravarty
    Balancing CXCL5 Levels Could Potentially Treat Lupus
    source: pixabay.com

    Balancing CXCL5 Levels Could Potentially Treat Lupus

    Currently, the standards-of-care for lupus include anti-malarial drugs such as hydroxychloroquine, corticosteroids and immune-suppressive therapies, and biologics such as Benlysta. But new therapies are urgently needed, especially as anywhere between…

    Continue Reading Balancing CXCL5 Levels Could Potentially Treat Lupus